Antimicrobial Peptides from Crowberry Endophytes for Microbial Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying endophytes and their antimicrobial metabolites are limited by culturing challenges, leading to incomplete biodiversity representation and short-lived bioactive production, while antibiotic resistance poses a significant threat due to the rapid development of microbial resistance.
Innovation Solution
Development of novel antimicrobial peptides derived from Crowberry (Empetrum nigrum) endophytes, specifically designed to enhance activity against a broad spectrum of microbes, including bacteria and fungi, with improved stability and minimal resistance development.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional culturing methods are used to study endophytes, then fast-growing strains can be isolated, but the full biodiversity is not represented
Solution Approach 1:
The patent segments the endophyte community into cultivable and uncultivable fractions, using specific culturing conditions to isolate different microbial groups. This allows representation of diverse endophyte populations that would otherwise be missed by conventional single-method approaches.
Solution Approach 2:
The patent employs multiple culturing parameters including different temperatures, media compositions, and incubation conditions to culture diverse endophyte strains. By varying these parameters, the method captures a broader spectrum of biodiversity while maintaining productive isolation rates.
2Productivity
If endophytes are cultured in vitro, then metabolites can be produced initially, but production stops after a certain period
Solution Approach 1:
The patent performs preliminary optimization of culturing conditions including media composition, temperature, and aeration to extend the productive phase. Pre-culturing protocols are established to maintain endophyte viability and metabolite production capacity over extended periods.
Solution Approach 2:
The patent implements continuous or repeated batch culturing systems that maintain endophytes in a metabolite-producing state. By optimizing nutrient supply and removing inhibitory metabolites, the system sustains bioactive compound production continuously rather than allowing it to cease after a single cycle.
3Reliability
If antibiotics are used to control microbes, then microbial growth is inhibited, but resistance develops rapidly
Solution Approach 1:
The patent uses antimicrobial peptides as natural alternatives to synthetic antibiotics. These peptides replicate the defensive functions of host immune systems and provide microbial control through mechanisms that are less prone to inducing resistance compared to conventional antibiotic approaches.
Solution Approach 2:
The patent employs complex antimicrobial peptide compositions with multiple amino acid sequences and structures. This composite approach creates multi-targeted antimicrobial activity that is harder for microbes to resist through single-mutation mechanisms, thereby maintaining long-term effectiveness.
Data Source
Figure 1~2
Figure 3A~3B
Figure 4a~4b
AI summary
The present invention relates to novel antimicrobial peptide and variants thereof. The invention further relates to method of killing or inhibiting growth of microbes and use of the peptide here disclosed as a medicament, feed additive, preservative or surfactant.